Funded Tech Companies
Edimer Pharmaceuticals
Researching who provided funding to Edimer Pharmaceuticals? Sanofi-Genzyme BioVentures, Third Rock Ventures and VI Partners joined the equity holders in this biopharmaceutical company.
Company Overview
Company Name
Edimer Pharmaceuticals
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
55 Cambridge Pkwy. 102W
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Website
Email Address
Company Background Information
Overview
Edimer is dedicated to developing EDI200 as a treatment for X-linked Hypohidrodic Ectodermal Dysplasia (XLHED). Learn more edimerpharma.com and XLHEDnetwork.com
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
7/30/2013
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Neil Kirby
VP - Operations
Ramsey Johnson
Company Investors
- Sanofi-Genzyme BioVentures (Bernard Davitian)
- Third Rock Ventures (Cary Pfeffer)
- VI Partners
- New Enterprise Associates (David Mott)
Browse more funded tech companies:
Share this article
About Our VC Funding Database
The company data above is provided by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs